Financial Snapshot

Revenue
$5.545M
TTM
Gross Margin
-45.47%
TTM
Net Earnings
-$4.744M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
78.55%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
$6.528M
Q3 2024
Cash
Q3 2024
P/E
-0.7914
Nov 29, 2024 EST
Free Cash Flow
-$713.0K
TTM

Revenues

Revenues

Revenue YoY Change

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001
Revenue $7.011M $8.104M $9.642M $10.87M $10.92M $12.33M $13.21M $15.57M $20.35M $22.13M $32.81M $54.51M $81.17M $74.39M $61.70M $50.97M $33.19M $21.84M $8.660M $20.00K $110.0K $40.00K $40.00K
YoY Change -13.48% -15.95% -11.27% -0.53% -11.41% -6.67% -15.15% -23.49% -8.05% -32.54% -39.81% -32.84% 9.11% 20.56% 21.05% 53.57% 51.97% 152.19% 43200.0% -81.82% 175.0% 0.0%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001
Revenue $7.011M $8.104M $9.642M $10.87M $10.92M $12.33M $13.21M $15.57M $20.35M $22.13M $32.81M $54.51M $81.17M $74.39M $61.70M $50.97M $33.19M $21.84M $8.660M $20.00K $110.0K $40.00K $40.00K
Cost Of Revenue $7.292M $8.598M $9.293M $8.914M $9.442M $10.36M $10.74M $12.35M $18.89M $19.47M $33.29M $40.43M $52.18M $44.11M $36.05M $25.68M $17.62M $11.75M $4.170M $50.00K $0.00 $0.00
Gross Profit -$281.1K -$493.9K $349.3K $1.953M $1.482M $1.975M $2.469M $3.219M $1.465M $2.668M -$480.0K $14.08M $28.99M $30.28M $25.65M $25.29M $15.57M $10.10M $4.490M -$30.00K $110.0K $110.0K
Gross Profit Margin -4.01% -6.09% 3.62% 17.97% 13.57% 16.02% 18.68% 20.67% 7.2% 12.05% -1.46% 25.83% 35.71% 40.71% 41.57% 49.62% 46.91% 46.25% 51.85% -150.0% 100.0% 275.0%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001
Selling, General & Admin $2.007M $2.963M $2.853M $4.153M $4.645M $5.771M $6.874M $7.389M $16.34M $36.42M $16.44M $7.720M $7.156M $5.582M $3.040M $5.560M $3.320M $1.470M $250.0K $90.00K $270.0K $750.0K $750.0K
YoY Change -32.27% 3.87% -31.31% -10.59% -19.5% -16.05% -6.97% -54.78% -55.13% 121.51% 112.95% 7.88% 28.19% 83.63% -45.32% 67.47% 125.85% 488.0% 177.78% -66.67% -64.0% 0.0%
% of Gross Profit 816.76% 212.67% 313.41% 292.22% 278.47% 229.57% 1115.59% 1364.83% 54.83% 24.69% 18.43% 11.85% 21.98% 21.32% 14.55% 5.57% 245.45% 681.82%
Research & Development $240.1K $185.9K $319.0K $378.0K $229.6K $172.4K $90.47K $366.0K $961.9K $2.799M $1.680M $440.0K
YoY Change 29.17% -41.73% -15.61% 64.59% 33.22% 90.54% -75.28% -61.95% -65.63% 66.58% 281.82%
% of Gross Profit 91.32% 19.35% 15.49% 8.73% 3.66% 11.37% 65.68% 104.89% 3.13%
Depreciation & Amortization $2.754M $2.701M $3.088M $2.679M $2.929M $3.259M $3.291M $3.078M $3.599M $1.786M $1.610M $1.460M $1.175M $1.505M $1.370M $720.0K $420.0K $400.0K $250.0K $0.00 $70.00K $80.00K $80.00K
YoY Change 1.97% -12.54% 15.24% -8.51% -10.12% -0.99% 6.93% -14.46% 101.5% 10.92% 10.27% 24.27% -21.95% 9.87% 90.28% 71.43% 5.0% 60.0% -100.0% -12.5% 0.0%
% of Gross Profit 884.08% 137.2% 197.6% 165.01% 133.33% 95.64% 245.71% 66.93% 10.37% 4.05% 4.97% 5.34% 2.85% 2.7% 3.96% 5.57% 63.64% 72.73%
Operating Expenses $2.471M $3.055M $3.210M $4.531M $4.875M $5.943M $6.965M $7.412M $15.66M $39.15M $18.12M $7.580M $7.264M $6.088M $3.030M $5.560M $3.320M $1.470M $240.0K $90.00K $270.0K $760.0K $760.0K
YoY Change -19.13% -4.82% -29.16% -7.05% -17.97% -14.67% -6.03% -52.67% -60.0% 116.06% 139.05% 4.35% 19.33% 100.91% -45.5% 67.47% 125.85% 512.5% 166.67% -66.67% -64.47% 0.0%
Operating Profit -$2.752M -$3.549M -$2.861M -$2.578M -$3.393M -$3.968M -$4.496M -$4.193M -$14.20M -$36.48M -$18.60M $6.500M $22.03M $24.66M $22.62M $19.73M $12.25M $8.630M $4.250M -$120.0K -$160.0K -$650.0K
YoY Change -22.46% 24.07% 10.95% -24.01% -14.51% -11.74% 7.22% -70.46% -61.09% 96.14% -386.15% -70.49% -10.7% 9.04% 14.65% 61.06% 41.95% 103.06% -3641.67% -25.0% -75.38%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001
Interest Expense -$327.0K $434.6K -$539.0K -$288.5K -$294.2K -$412.7K -$474.9K -$719.0K -$1.045M -$716.1K -$340.0K -$300.0K -$255.2K -$168.3K -$120.0K -$90.00K -$210.0K -$150.0K -$190.0K -$10.00K -$50.00K -$180.0K -$180.0K
YoY Change -175.24% -180.64% 86.83% -1.94% -28.72% -13.09% -33.95% -31.21% 45.97% 110.61% 13.33% 17.56% 51.67% 40.22% 33.33% -57.14% 40.0% -21.05% 1800.0% -80.0% -72.22% 0.0%
% of Operating Profit -4.62% -1.16% -0.68% -0.53% -0.46% -1.71% -1.74% -4.47%
Other Income/Expense, Net -$327.0K -$423.9K -$539.0K $0.00 -$140.0K $300.0K $470.0K $0.00 -$100.0K $610.0K $110.0K -$10.00K $0.00 $0.00 $0.00
YoY Change -22.85% -21.36% -100.0% -146.67% -36.17% -100.0% -116.39% 454.55% -1200.0%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001
Pretax Income -$3.079M -$3.973M -$3.399M -$2.867M -$20.70M -$10.86M -$19.15M -$8.874M -$15.35M -$39.47M -$18.95M $5.600M $686.3K $1.436M $22.49M $19.54M $12.66M $8.590M $4.050M -$510.0K -$520.0K -$1.100M -$1.100M
YoY Change -22.5% 16.87% 18.58% -86.15% 90.62% -43.3% 115.84% -42.17% -61.13% 108.3% -438.39% 716.01% -52.21% -93.61% 15.1% 54.34% 47.38% 112.1% -894.12% -1.92% -52.73% 0.0%
Income Tax $0.00 $0.00 -$110.0K $122.6K $308.2K $60.44K $77.04K $1.060M $980.0K -$3.442M -$2.686M $2.260M $1.710M -$160.0K $0.00 $250.0K $0.00 $0.00 $0.00 $0.00
% Of Pretax Income 17.5% -501.6% -187.07% 10.05% 8.75% -1.26% 0.0% 6.17%
Net Earnings -$3.079M -$3.973M -$3.399M -$2.867M -$20.70M -$10.75M -$19.28M -$9.183M -$15.41M -$39.55M -$20.01M $4.620M $19.27M $23.41M $20.23M $17.83M $12.82M $8.590M $3.800M -$510.0K -$520.0K -$1.100M -$1.100M
YoY Change -22.5% 16.87% 18.58% -86.15% 92.57% -44.23% 109.94% -40.39% -61.05% 97.65% -533.12% -76.02% -17.7% 15.74% 13.46% 39.08% 49.24% 126.05% -845.1% -1.92% -52.73% 0.0%
Net Earnings / Revenue -43.91% -49.02% -35.26% -26.38% -189.51% -87.18% -145.91% -58.97% -75.7% -178.69% -60.99% 8.48% 23.74% 31.48% 32.79% 34.98% 38.63% 39.33% 43.88% -2550.0% -472.73% -2750.0% -2750.0%
Basic Earnings Per Share -$0.91 -$0.76 -$0.74 $0.44 $0.54
Diluted Earnings Per Share -$0.91 -$0.76 -$73.69K -$65.72K -$475.0K -$246.7K -$442.4K -$210.7K -$353.5K -$907.6K -$459.2K $106.0K $0.44 $0.54 $478.5K $443.3K $344.1K $247.4K $336.6K -$894.7K -$1.576M -$3.929M -$3.929M

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

No data

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001
Cash & Short-Term Investments $1.424M $2.030M $4.859M $957.7K $1.075M $1.187M $2.030M $2.666M $6.249M $5.296M $6.000M $4.000M $4.100M $3.700M $3.600M $6.900M $1.800M $700.0K $500.0K $0.00 $0.00 $0.00 $0.00
YoY Change -29.86% -58.22% 407.39% -10.91% -9.41% -41.55% -23.84% -57.34% 17.99% -11.74% 50.0% -2.44% 10.81% 2.78% -47.83% 283.33% 157.14% 40.0%
Cash & Equivalents $1.424M $2.030M $4.859M $957.7K $1.075M $1.187M $2.030M $2.666M $6.249M $5.296M $6.000M $4.000M $4.100M $3.700M $3.600M $6.900M $1.800M $700.0K $500.0K $0.00 $0.00 $0.00 $0.00
Short-Term Investments
Other Short-Term Assets $110.3K $77.70K $58.79K $73.67K $187.0K $1.398M $895.5K $1.315M $339.1K $404.4K $0.00 $1.000M $600.0K $500.0K $300.0K $500.0K $0.00 $100.0K $0.00
YoY Change 41.9% 32.17% -20.2% -60.61% -86.62% 56.09% -31.92% 287.82% -16.13% -100.0% 66.67% 20.0% 66.67% -40.0% -100.0%
Inventory $3.733M $2.948M $3.340M $3.705M $3.589M $5.055M $6.407M $7.311M $9.663M $15.32M $24.70M $36.40M $30.40M $20.40M $14.20M $13.10M $14.40M $10.30M $5.800M
Prepaid Expenses
Receivables $504.4K $421.5K $714.5K $501.9K $635.4K $916.9K $2.293M $4.000M $5.174M $13.85M $45.10M $66.20M $69.70M $61.90M $51.20M $36.00M $18.50M $12.10M $5.600M $0.00 $0.00 $0.00
Other Receivables $225.9K $487.6K $121.4K $83.63K $92.80K $190.7K $664.2K $2.228M $2.824M $7.038M $8.200M $5.000M $5.900M $5.400M $1.900M $3.200M $4.100M $2.600M $2.600M $0.00 $0.00 $0.00
Total Short-Term Assets $5.997M $5.965M $9.093M $5.322M $5.579M $8.747M $12.29M $17.52M $24.25M $41.91M $84.00M $112.5M $110.6M $91.90M $71.30M $59.70M $38.80M $25.70M $14.50M $0.00 $0.00 $0.00 $0.00
YoY Change 0.54% -34.41% 70.87% -4.61% -36.22% -28.83% -29.85% -27.75% -42.15% -50.1% -25.33% 1.72% 20.35% 28.89% 19.43% 53.87% 50.97% 77.24%
Property, Plant & Equipment $7.217M $10.01M $13.41M $15.61M $16.45M $19.29M $23.54M $24.97M $29.39M $33.88M $30.20M $9.000M $6.300M $6.400M $6.700M $6.700M $2.600M $2.700M $2.800M $0.00 $400.0K $400.0K
YoY Change -27.92% -25.33% -14.12% -5.09% -14.74% -18.04% -5.71% -15.06% -13.25% 12.19% 235.56% 42.86% -1.56% -4.48% 0.0% 157.69% -3.7% -3.57% -100.0% 0.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $17.07M $23.72M $35.50M $42.03M $43.97M $41.70M $39.30M $36.40M $4.400M $3.600M $2.800M $200.0K $0.00 $100.0K
YoY Change -100.0% -28.05% -33.17% -15.54% -4.41% 5.45% 6.11% 7.97% 727.27% 22.22% 28.57% 1300.0% -100.0%
Total Long-Term Assets $10.47M $11.82M $13.56M $15.80M $16.66M $36.63M $47.66M $61.00M $72.26M $79.17M $73.60M $50.70M $45.80M $39.90M $29.60M $15.80M $4.900M $2.800M $3.000M $0.00 $0.00 $400.0K $400.0K
YoY Change -11.4% -12.81% -14.18% -5.16% -54.53% -23.15% -21.86% -15.59% -8.72% 7.57% 45.17% 10.7% 14.79% 34.8% 87.34% 222.45% 75.0% -6.67% -100.0% 0.0%
Total Assets $16.47M $17.78M $22.65M $21.12M $22.24M $45.38M $59.95M $78.52M $96.51M $121.1M $157.6M $163.2M $156.4M $131.8M $100.9M $75.50M $43.70M $28.50M $17.50M $0.00 $0.00 $400.0K $400.0K
YoY Change
Accounts Payable $966.4K $667.1K $926.8K $1.235M $1.366M $1.061M $1.141M $3.060M $2.439M $2.551M $1.900M $2.800M $3.100M $4.900M $4.000M $1.000M $300.0K $500.0K $700.0K $100.0K $0.00 $0.00 $0.00
YoY Change 44.87% -28.02% -24.93% -9.64% 28.79% -7.03% -62.71% 25.46% -4.37% 34.25% -32.14% -9.68% -36.73% 22.5% 300.0% 233.33% -40.0% -28.57% 600.0%
Accrued Expenses $376.6K $445.3K $383.7K $229.4K $281.2K $310.8K $276.4K $139.8K $143.4K $269.9K $300.0K $2.600M $3.300M $2.500M $1.600M $1.200M $600.0K $300.0K $600.0K $100.0K $0.00 $0.00
YoY Change -15.43% 16.03% 67.25% -18.41% -9.53% 12.46% 97.65% -2.5% -46.86% -10.04% -88.46% -21.21% 32.0% 56.25% 33.33% 100.0% 100.0% -50.0%
Deferred Revenue
YoY Change
Short-Term Debt $1.971M $6.241M $4.329M $2.038M $109.9K $1.274M $709.8K $1.089M $4.622M $4.887M $4.900M $4.800M $3.900M $3.800M $3.800M $2.500M $2.700M $6.500M $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -68.42% 44.17% 112.37% 1754.56% -91.37% 79.48% -34.81% -76.44% -5.43% -0.26% 2.08% 23.08% 2.63% 0.0% 52.0% -7.41% -58.46%
Long-Term Debt Due $0.00 $2.299M $2.150M $2.181M $2.305M $1.440M $1.541M $1.629M $600.0K $400.0K $400.0K
YoY Change -100.0% 6.92% -1.43% -5.38% 60.08% -6.52% -5.43% 50.0% 0.0%
Total Short-Term Liabilities $6.821M $12.74M $10.51M $11.40M $10.05M $10.05M $9.227M $10.40M $12.79M $14.17M $12.00M $14.60M $13.80M $12.80M $10.50M $5.600M $3.900M $7.600M $5.800M $100.0K $900.0K $700.0K $700.0K
YoY Change -46.46% 21.17% -7.81% 13.52% -0.06% 8.93% -11.26% -18.71% -9.74% 18.1% -17.81% 5.8% 7.81% 21.9% 87.5% 43.59% -48.68% 31.03% 5700.0% -88.89% 28.57% 0.0%
Long-Term Debt $1.412M $0.00 $5.250M $904.2K $2.150M $4.363M $6.916M $8.641M $10.78M $11.40M $12.50M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $100.0K $300.0K $300.0K
YoY Change -100.0% 480.6% -57.95% -50.71% -36.92% -19.96% -19.88% -5.43% -8.77% -100.0% -66.67% 0.0%
Other Long-Term Liabilities $39.91K $0.00 $44.18K $0.00 $48.70K $0.00 $0.00 $900.0K $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Total Long-Term Liabilities $1.452M $0.00 $5.294M $904.2K $2.199M $4.363M $6.916M $8.641M $10.78M $11.40M $12.50M $0.00 $0.00 $900.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $100.0K $300.0K $300.0K
YoY Change -100.0% 485.49% -58.88% -49.6% -36.92% -19.96% -19.88% -5.43% -8.77% -100.0% -100.0% -66.67% 0.0%
Total Liabilities $9.015M $13.49M $16.63M $13.11M $13.00M $15.18M $16.88M $19.61M $23.87M $28.34M $24.70M $14.70M $13.90M $13.80M $10.50M $5.600M $3.900M $7.700M $5.800M $100.0K $1.000M $1.000M $1.000M
YoY Change -33.2% -18.87% 26.83% 0.89% -14.37% -10.09% -13.92% -17.85% -15.78% 14.75% 68.03% 5.76% 0.72% 31.43% 87.5% 43.59% -49.35% 32.76% 5700.0% -90.0% 0.0% 0.0%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

No data

Preferred Stock

No data

Treasury Stock Shares

No data

Stock Issuance & Repurchase

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001
Basic Shares Outstanding 3.384M shares 5.257M shares 4.613M shares
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Dividends

No data

Stock Price

Market Cap: $3.7544 Million

About CHINA PHARMA HOLDINGS, INC.

China Pharma Holdings, Inc. engages in the development, manufacture, and marketing of pharmaceutical products. The company is headquartered in Haikou, Hainan and currently employs 231 full-time employees. The company went IPO on 2000-02-15. The firm's products are for human use in connection, and with a variety of high-incidence and high-mortality diseases and medical conditions prevalent. The firm manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. In addition, the Company is also engaged in the production of comprehensive healthcare products and protective products.

Industry: Pharmaceutical Preparations Peers: China SXT Pharmaceuticals, Inc. SUNWIN STEVIA INTERNATIONAL, INC. BGM Group Ltd. Universe Pharmaceuticals INC